First Trust Advisors Portfolio holdings
AUM
$124B
This Quarter Return
+1.31%
1 Year Return
+23.24%
3 Year Return
+77.03%
5 Year Return
+144.93%
10 Year Return
+396.84%
AUM
$38.5B
AUM Growth
+$38.5B
(+13%)
Cap. Flow
+$4.53B
Cap. Flow
% of AUM
11.77%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,186
Reduced
889
Closed
134
Top Buys
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$230M |
| 2 |
Spectrum Brands
SPB
|
$81.6M |
| 3 |
Chevron
CVX
|
$73.3M |
| 4 |
CIM
Chimera Investment
CIM
|
$70.9M |
| 5 |
Pfizer
PFE
|
$65.1M |
Sector Composition
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.83% |
| 4 | Consumer Staples | 8.03% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Akamai
AKAM
$11.3B
| $127M | 0.33% | 1,813,248 +279,647 | +18% | +$19.5M |
|
52
Pilgrim's Pride
PPC
$10.6B
| $126M | 0.33% | 5,482,262 +2,310,107 | +73% | +$53.1M |
|
53
Vertex Pharmaceuticals
VRTX
$100B
| $124M | 0.32% | 1,001,124 +150,498 | +18% | +$18.6M |
|
54
AT&T
T
$209B
| $123M | 0.32% | 3,467,834 -1,064,074 | -23% | -$37.8M |
|
55
Archer Daniels Midland
ADM
$30.1B
| $123M | 0.32% | 2,551,639 +492,431 | +24% | +$23.7M |
|
56
Cisco
CSCO
$274B
| $123M | 0.32% | 4,478,378 +528,019 | +13% | +$14.5M |
|
57
Nektar Therapeutics
NKTR
$568M
| $122M | 0.32% | 9,726,344 +3,421,229 | +54% | +$42.8M |
|
58
Centene
CNC
$14.3B
| $120M | 0.31% | 1,493,092 -33,661 | -2% | -$2.71M |
|
59
Agios Pharmaceuticals
AGIO
$2.19B
| $120M | 0.31% | +1,079,286 | New | +$120M |
|
60
Monster Beverage
MNST
$60.9B
| $119M | 0.31% | 889,325 -303,825 | -25% | -$40.7M |
|
61
Alkermes
ALKS
$4.78B
| $119M | 0.31% | 1,851,233 -268,527 | -13% | -$17.3M |
|
|
RAD
62
DELISTED
Rite Aid Corporation
RAD
| $118M | 0.31% | 14,168,321 -310,444 | -2% | -$2.59M |
|
|
ICPT
63
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $118M | 0.31% | 487,459 -150,815 | -24% | -$36.4M |
|
|
CTRX
64
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $117M | 0.3% | 1,908,748 +171,735 | +10% | +$10.5M |
|
65
McKesson
MCK
$85.4B
| $115M | 0.3% | 513,523 +96,087 | +23% | +$21.6M |
|
|
AGN
66
DELISTED
Allergan plc
AGN
| $115M | 0.3% | 379,818 -9,252 | -2% | -$2.81M |
|
|
QGENF
67
DELISTED
QIAGEN NV
QGENF
| $115M | 0.3% | 4,620,861 -42,007 | -0.9% | -$1.04M |
|
68
Cencora
COR
$56.5B
| $114M | 0.3% | 1,072,711 +27,543 | +3% | +$2.93M |
|
|
MNK
69
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $114M | 0.3% | 967,863 +211,998 | +28% | +$25M |
|
70
Equinix
EQIX
$76.9B
| $114M | 0.29% | 447,282 +56,761 | +15% | +$14.4M |
|
|
PDLI
71
DELISTED
PDL BioPharma, Inc.
PDLI
| $113M | 0.29% | 17,536,793 +3,424,045 | +24% | +$22M |
|
72
HCA Healthcare
HCA
$94.5B
| $113M | 0.29% | 1,241,512 -1,845 | -0.1% | -$167K |
|
73
Procter & Gamble
PG
$368B
| $111M | 0.29% | 1,423,714 +1,127,697 | +381% | +$88.2M |
|
74
Expedia Group
EXPE
$26.6B
| $111M | 0.29% | 1,018,105 +176,220 | +21% | +$19.3M |
|
|
LNKD
75
DELISTED
LinkedIn Corporation
LNKD
| $110M | 0.29% | 534,343 +120,711 | +29% | +$24.9M |
|